Nimotuzumab
About Nimotuzumab
Nimotuzumab is a targeted cancer medicine given into a vein to treat certain cancers. It targets a protein called EGFR, which is found on the surface of some cancer cells and helps them grow. Depending on the cancer and approved use, this medicine may be given with radiotherapy, chemotherapy, or other cancer treatment.
This medicine is used for certain head and neck cancers and some brain tumours. In India, nimotuzumab has also been used for other approved cancer indications, including nasopharyngeal cancer (cancer that starts in the upper part of the throat behind the nose). Your oncologist will decide whether this treatment is suitable based on the type of cancer, its features, and your overall treatment plan.
Nimotuzumab is given as a slow infusion into a vein by a healthcare professional in a hospital or cancer treatment centre. The dose and schedule depend on the cancer being treated and the other treatments you receive. Your healthcare team will monitor you during and after the infusion and may give medicines beforehand to reduce the chance of an infusion reaction.
Some people may develop fever, chills, nausea, tiredness, or skin changes during treatment. Infusion reactions can also occur, particularly during or shortly after the medicine is given. Consult your doctor right away if you develop difficulty breathing, swelling of the face or throat, severe dizziness, chest discomfort, or a severe skin reaction.
Before treatment, tell your doctor about all your health conditions, including any active infection or serious heart, lung, liver, or kidney problems. Your healthcare team may perform blood tests and other checks before and during treatment. Tell your doctor about all medicines you take and if you are pregnant, planning to become pregnant, breastfeeding, are an older adult, or if the medicine is intended for a child.
Uses of Nimotuzumab
Medicinal Benefits
Nimotuzumab provides targeted treatment for certain cancers that depend on EGFR signals for growth. Its benefits depend on the type and stage of cancer and the other treatments being given.
- Helps control cancer growth: By blocking EGFR signals, this medicine can slow the growth and division of certain cancer cells.
- Supports other cancer treatments: When used with radiotherapy or chemotherapy, it may help improve the cancer's response to treatment in certain approved settings.
- May help reduce cancer-related symptoms: If the cancer responds and the tumour becomes smaller or stops growing, symptoms caused by the tumour may improve.
- May cause fewer severe skin reactions than some similar medicines: Clinical studies suggest that severe skin reactions may occur less often with nimotuzumab than with some other EGFR-targeted medicines, although side effects and individual responses can vary.
Directions for Use
- Follow your doctor's instructions on the dosage and timing of this medication.
- Nimotuzumab is administered by the doctor or nurse.
- Do not self-administer.
Storage
Side Effects of Nimotuzumab
Common Side Effects (Usually Mild)
- Fever or chills during or after the infusion
- Nausea or vomiting
- Feeling tired or weak
- Mild skin rash, dryness, or itching
- Headache or dizziness
Serious Side Effects (Consult your doctor right away)
- Difficulty breathing, wheezing, or tightness in the chest
- Swelling of the face, lips, tongue, or throat
- Severe dizziness, fainting, or a sudden change in blood pressure
- Severe or widespread rash, blistering, or peeling of the skin
- New or worsening shortness of breath or persistent cough
- Signs of a serious infection, such as persistent fever or feeling very unwell
Medicines Containing this Salt
View AllDrug Warnings
- Attend your appointments: Keep all scheduled infusion and monitoring appointments so your healthcare team can assess your response and manage side effects.
- Be aware of infusion reactions: Fever, chills, rash, dizziness, or breathing problems can occur during or after an infusion. Tell your healthcare team immediately if you notice these symptoms while receiving treatment.
- Complete recommended tests: Your doctor may arrange blood tests and other checks before and during treatment to monitor your general health and how your organs are working.
- Report infections: Tell your doctor if you have an infection before an infusion or develop persistent fever, chills, or other signs of infection during treatment.
- Share your medical history: Tell your doctor about serious heart, lung, liver, or kidney problems and any previous severe reaction to nimotuzumab or similar medicines.
- Discuss other treatments: Tell your healthcare team about all medicines, supplements, vaccines, chemotherapy, and other cancer treatments you receive so they can check that your overall treatment plan is safe.
- Discuss pregnancy and breastfeeding: Tell your doctor if you are pregnant, planning a pregnancy, or breastfeeding so they can explain the potential risks and appropriate precautions.
Drug Interactions
- Platinum medicines such as cisplatin: Nimotuzumab may be given with platinum-based chemotherapy for certain cancers. The healthcare team will monitor for side effects related to the complete treatment regimen.
- Taxanes such as paclitaxel or docetaxel: These chemotherapy medicines may be used in cancer treatment plans that include targeted therapy. Your oncologist will consider the benefits, side effects, and monitoring needed when treatments are combined.
- Other cancer medicines: Tell your doctor about every cancer medicine you receive because combinations can change the type or severity of side effects and may require additional monitoring.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
consult your doctorIt is not known if alcohol affects Nimotuzumab. Please consult the doctor.
Pregnancy
cautionConsult the doctor if you are pregnant. It should be used during pregnancy only if the benefits outweigh the risks.
Breast Feeding
cautionIt is not known if this medicine passes into breast milk. Consult the doctor if you are breastfeeding.
Driving
consult your doctorIt is unknown if Nimotuzumab affects your ability to drive. Drive only if you are alert.
Liver
consult your doctorIf you have a history of liver problems, inform the doctor before receiving Nimotuzumab.
Kidney
consult your doctorIf you have a history of kidney problems, inform the doctor before receiving Nimotuzumab.
Children
cautionPlease consult the doctor if you have any concerns regarding the usage of Nimotuzumab in children.
Habit Forming
Diet & Lifestyle Advise
- Stay hydrated: Drink enough fluids unless your healthcare team has advised you to limit them, particularly if other cancer treatments cause vomiting, diarrhoea, or difficulty eating and drinking.
- Choose nourishing foods: Eat a balanced diet with enough protein and calories to help maintain your strength during cancer treatment. Ask your healthcare team for dietary support if eating becomes difficult.
- Choose soft foods when needed: If treatment for head and neck cancer makes chewing or swallowing uncomfortable, softer foods may be easier to manage.
- Care for your skin: Use gentle skin products and moisturiser if your skin becomes dry or irritated. Ask your healthcare team before using medicated creams on a treatment-related rash.
- Look after your mouth: Keep your mouth and teeth clean, particularly if chemotherapy or radiotherapy causes mouth soreness. Your healthcare team can recommend suitable mouth care if needed.
Patients Concern
Disease/Condition Glossary
Head and neck cancer: Head and neck cancer includes cancer in the throat, larynx, nose, lips, mouth, and salivary glands. The risk of head and neck cancer increases with heavy alcohol use, tobacco use, and infection with human papillomavirus (HPV). Symptoms include persistent sore throat, changes in voice, trouble swallowing, and a sore or lump that does not heal.
FAQs
Nimotuzumab is used to treat Head and neck cancer.
Nimotuzumab works by binding to receptors on cancer cells and prevents them from destroying the body’s immune system. Thereby, it helps treat cancer.
Nimotuzumab may cause hypertension (high blood pressure) and fluctuation in blood pressure. Consult the doctor if you have high blood pressure or if you experience fluctuation in blood pressure.
Mucositis (swelling and irritation of mucosa) could be a side effect of Nimotuzumab. If the condition persists or worsens, consult the doctor.
This medicine is given slowly into a vein by a trained healthcare professional in a hospital or cancer treatment centre. You will be monitored during and after the infusion for possible reactions.
Nimotuzumab targets EGFR, a protein that helps some cancer cells grow. Depending on the type of cancer and treatment plan, your doctor may use tumour tests and other clinical information to decide whether EGFR-targeted treatment is suitable for you.
For some cancers, nimotuzumab is used with chemotherapy or radiotherapy as part of the planned treatment. Blocking EGFR may make cancer cells more responsive to these treatments. The combination used depends on your type of cancer and treatment plan.
Your healthcare team may give medicines before the infusion to reduce the chance or severity of an infusion reaction when appropriate. The exact preparation depends on your treatment plan and previous reactions.
Tell your nurse or doctor immediately if you develop chills, rash, dizziness, breathing difficulty, chest discomfort, or swelling during the infusion. The healthcare team can slow or stop the infusion and provide treatment if needed.
Skin dryness or rash can occur. Studies suggest severe skin reactions may occur less often with nimotuzumab than with some other EGFR-targeted medicines, but individual responses vary. Consult your doctor right away if a rash becomes severe, painful, blistered, or starts peeling.
Nimotuzumab itself is not typically associated with the same degree of hair loss as many chemotherapy medicines. However, hair loss may occur if chemotherapy or radiotherapy that affects hair growth is given at the same time.
Your healthcare team may arrange blood tests and other checks before and during treatment to assess your general health, organ function, treatment response, and side effects. The tests you need depend on your cancer and the other treatments you receive.
Your oncologist will check how your cancer is responding using examinations, scans, or other tests. If the cancer continues to grow or the treatment is not providing enough benefit, your doctor may stop or change the treatment and discuss other suitable options with you.
The length of treatment depends on your type of cancer, treatment plan, response, and side effects. Your oncologist will review your progress regularly and decide whether treatment should continue, change, or stop.
Ask your healthcare team before receiving any vaccine during cancer treatment. Whether a vaccine is suitable depends on this medicine, other treatments you receive, and how well your immune system is working.
Tell your doctor if you are pregnant, planning a pregnancy, or breastfeeding before treatment. Your doctor will discuss the potential risks and whether this medicine is appropriate for you.
Author Details
